BEIGF
Price
$15.14
Change
+$1.12 (+7.99%)
Updated
Jan 14 closing price
Capitalization
27.08B
CMRX
Price
$8.46
Change
+$0.03 (+0.36%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
784.39M
51 days until earnings call
Ad is loading...

BEIGF vs CMRX

Header iconBEIGF vs CMRX Comparison
Open Charts BEIGF vs CMRXBanner chart's image
BeiGene
Price$15.14
Change+$1.12 (+7.99%)
Volume$100
Capitalization27.08B
Chimerix
Price$8.46
Change+$0.03 (+0.36%)
Volume$80.25K
Capitalization784.39M
BEIGF vs CMRX Comparison Chart
Loading...
CMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEIGF vs. CMRX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEIGF is a Hold and CMRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (BEIGF: $15.14 vs. CMRX: $8.43)
Brand notoriety: BEIGF and CMRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEIGF: 94% vs. CMRX: 149%
Market capitalization -- BEIGF: $27.08B vs. CMRX: $784.39M
BEIGF [@Biotechnology] is valued at $27.08B. CMRX’s [@Biotechnology] market capitalization is $784.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEIGF’s FA Score shows that 0 FA rating(s) are green whileCMRX’s FA Score has 0 green FA rating(s).

  • BEIGF’s FA Score: 0 green, 5 red.
  • CMRX’s FA Score: 0 green, 5 red.
According to our system of comparison, CMRX is a better buy in the long-term than BEIGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMRX’s TA Score shows that 3 TA indicator(s) are bullish.

  • CMRX’s TA Score: 3 bullish, 4 bearish.

Price Growth

BEIGF (@Biotechnology) experienced а 0.00% price change this week, while CMRX (@Biotechnology) price change was +60.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

CMRX is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEIGF($27.1B) has a higher market cap than CMRX($784M). CMRX YTD gains are higher at: 142.241 vs. BEIGF (7.989). CMRX has higher annual earnings (EBITDA): -92.74M vs. BEIGF (-727.23M). BEIGF has more cash in the bank: 2.7B vs. CMRX (136M). CMRX has less debt than BEIGF: CMRX (644K) vs BEIGF (1.1B). BEIGF has higher revenues than CMRX: BEIGF (3.32B) vs CMRX (159K).
BEIGFCMRXBEIGF / CMRX
Capitalization27.1B784M3,457%
EBITDA-727.23M-92.74M784%
Gain YTD7.989142.2416%
P/E RatioN/AN/A-
Revenue3.32B159K2,086,164%
Total Cash2.7B136M1,987%
Total Debt1.1B644K170,963%
FUNDAMENTALS RATINGS
CMRX: Fundamental Ratings
CMRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMRX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Ad is loading...
CMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KROP10.400.26
+2.56%
Global X AgTech & Food Innovation ETF
WDIV65.780.85
+1.31%
SPDR® S&P Global Dividend ETF
AVES47.860.33
+0.69%
Avantis Emerging Markets Value ETF
IHDG45.810.24
+0.53%
WisdomTree Intl Hdgd Qual Div Gr ETF
FFTY26.71-0.25
-0.93%
Innovator IBD® 50 ETF

BEIGF and

Correlation & Price change

A.I.dvisor tells us that BEIGF and GOVX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEIGF and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEIGF
1D Price
Change %
BEIGF100%
N/A
GOVX - BEIGF
29%
Poorly correlated
-6.56%
CING - BEIGF
29%
Poorly correlated
+0.78%
CMRX - BEIGF
27%
Poorly correlated
N/A
POLBF - BEIGF
25%
Poorly correlated
N/A
TSVT - BEIGF
11%
Poorly correlated
-6.99%
More

CMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMRX has been loosely correlated with QURE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CMRX jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
N/A
QURE - CMRX
57%
Loosely correlated
-2.24%
NAMS - CMRX
49%
Loosely correlated
+1.28%
AUPH - CMRX
37%
Loosely correlated
-0.49%
CRDF - CMRX
37%
Loosely correlated
-0.64%
FGEN - CMRX
35%
Loosely correlated
-5.00%
More